Good candidates for peptides for weight loss generally include people who have: A body mass index (BMI) of 30 or higher A BMI of 27 or higher paired with a weight-related health condition, such as high blood pressure, high cholesterol, or diabetes Ongoing struggles with stubborn belly fat or a slow metabolism Age-related fat gain, particularly common among men in their 30s, 40s, 50s, and beyond A weight-loss plateau despite staying consistent with exercise and a clean diet Weight gain linked to a hormonal imbalance or low testosterone Peptide therapy is not appropriate for everyone, however
Billings, MD, MMSc The next steps involve launching Phase 3 clinical trials, which will study eloralintide in a much larger and more diverse group of participants to further examine eloralintides effectiveness and long-term safety, she added
These adverse effects can be uncomfortable and may deter individuals from continuing supplementation
As with any medication in phase 3, well continue to learn more about the long-term safety profile before and after FDA approval, Janese Laster-Butler, MD, a gastroenterologist, obesity medicine physician, and owner of Gut Theory Total Digestive Care, told Health
Trials have flagged signals to monitor